Skip to main content
SpringerLink
Log in

Fibromyalgia

  • Chapter
Pain Management and Palliative Care

  • 3116 Accesses

Abstract

Fibromyalgia is a chronic widespread pain condition affecting 2–5 % of the adult population. It is often seen in outpatient practice. Fibromyalgia is a clinical diagnosis based on signs and symptoms. Classically it presents with widespread pain, fatigue, and sleep disturbance. For some patients this could be a debilitating disorder affecting quality of life and social participation. Though historically there had been much debate about the validity of fibromyalgia as a “true” medical condition, recent research shows evidence of aberrant pain processing in fibromyalgia patients. This chapter will cover how to diagnose, work up, and manage this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACR:

American College of Rheumatology

ANA:

Antinuclear antibodies, ANA antinuclear antibody

CAPP:

Central amplification of pain perception

CBC:

Complete blood count

CBT:

Cognitive behavioral therapy

CFIDS:

Chronic fatigue immune dysfunction syndrome

CMP:

Complete metabolic panel

CPK:

Creatine phosphokinase

CRP:

C reactive protein

ESR:

Erythrocyte sedimentation rate

FDA:

Food and drug administration

FIQ:

Fibromyalgia impact questionnaire

FIQR:

Fibromyalgia impact questionnaire revised

FM FibromyalgiaGABA:

Gamma-aminobutyric acid

GI:

Gastrointestinal

GU:

Genitourinary

HEENT:

Head, eyes, ears, neck, throat

HIV:

Human immunodeficiency virus

HLA:

Human leukocyte antigen

HTLV:

Human T-lymphotropic virus

MSK:

Musculoskeletal

mVASFIQ:

Fibromyalgia impact questionnaire

NSAIDs:

Nonsteroidal anti-inflammatory drugs

OA:

Osteoarthritis

OSA:

Obstructive sleep apnea

OT:

Occupational therapy

PT:

Physical therapy

RA:

Rheumatoid arthritis

RF:

Rheumatoid factor

SNRIs:

Serotonin-norepinephrine reuptake inhibitors

SSI:

Symptom severity index

SSRI:

Selective serotonin reuptake inhibitors

TCA:

Tricyclic antidepressant/s

TMJ:

Temporomandibular disorder

TSH:

Thyroid-stimulating hormone

WPI:

Widespread pain index

References

  1. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130:910–21.

    Article  CAS  PubMed  Google Scholar 

  2. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–72.

    Article  CAS  PubMed  Google Scholar 

  3. Wolfe F, Clauw D, Fitzcharles MA, Goldenberg D, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600–10.

    Article  Google Scholar 

  4. Wolfe F, Häuser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011;43(7):495–502.

    Article  PubMed  Google Scholar 

  5. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2008;58(1):26–35.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Clauw DJ, Arnold LM, McCarberg BH, FibroCollaborative. The science of fibromyalgia. Mayo Clin Proc. 2011;86(9):907–11.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Saxena A, Solitar BM. Fibromyalgia knowns, unknowns, and current treatment. Bull NYU Hosp Jt Dis. 2010;68(3):157–61.

    Google Scholar 

  8. Staud R. Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des. 2006;12(1):23–7.

    Article  CAS  PubMed  Google Scholar 

  9. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944–52.

    Article  PubMed  Google Scholar 

  10. Mease PJ, Clauw DJ, Arnold LM, et al. Fibromyalgia syndrome. J Rheumatol. 2005;32(11):2270–7.

    PubMed  Google Scholar 

  11. Arnold LM, Clauw DJ, McCarberg BH, FibroCollaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011;86(5):457–64.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10(8):777–91.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Ablin K, Clauw DJ. From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. Rheum Dis Clin North Am. 2009;35(2):233–51.

    Article  PubMed  Google Scholar 

  14. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67(8):1219–25.

    Article  PubMed  Google Scholar 

  15. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004;66(6):837–44.

    Article  PubMed  Google Scholar 

  16. Yunus MB. A comprehensive medical evaluation of patients with fibromyalgia syndrome. Rheum Dis Clin North Am. 2002;28(2):201–17, v–vi.

    Article  PubMed  Google Scholar 

  17. Schneider MJ. Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis. J Manipulative Physiol Ther. 1995;18(6):398–406.

    CAS  PubMed  Google Scholar 

  18. Hans SC, Harrison P. Myofascial pain syndrome and trigger point management. Reg Anesth. 1999;22:89–101.

    Google Scholar 

  19. Arnold LM, Clauw DJ, Dunegan LJ, Turk DC, FibroCollaborative. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc. 2012;87(5):488–96.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Lee SJ, Kim DY, Chun MH, Kim YG. The effect of repetitive transcranial magnetic stimulation on fibromyalgia: a randomized sham-controlled trial with 1-mo follow-up. Am J Phys Med Rehabil. 2012;91(12):1077–85.

    Article  PubMed  Google Scholar 

  21. Moretti FA, Marcondes FB, Provenza JR, Fukuda TY, de Vasconcelos RA, Roizenblatt S. Combined therapy (ultrasound and interferential current) in patients with fibromyalgia: once or twice in a week? Physiother Res Int. 2012;17(3):142–9.

    Article  PubMed  Google Scholar 

  22. Gur A. Physical therapy modalities in management of fibromyalgia. Curr Pharm Des. 2006;12(1):29–35.

    Article  CAS  PubMed  Google Scholar 

  23. Han C, Lee SJ, Lee SY, Seo HJ, Wang SM, Park MH, Patkar AA, Koh J, Masand PS, Pae CU. Available therapies and current management of fibromyalgia: focusing on pharmacological agents. Drugs Today (Barc). 2011;47(7):539–57.

    Article  Google Scholar 

  24. Mease PJ, Dundon K, Sarzi-Puttini P. Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol. 2011;25(2):285–97.

    Article  CAS  PubMed  Google Scholar 

  25. Tort S, Urrútia G, Nishishinya MB, Walitt B. Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2012;(4):CD009807.

    Google Scholar 

  26. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;(3):CD007938.

    Google Scholar 

  27. Hearn L, Derry S, Moore RA. Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;(2):CD009318.

    Google Scholar 

  28. Birse F, Derry S, Moore RA. Phenytoin for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;(5):CD009485.

    Google Scholar 

  29. Corrigan R, Derry S, Wiffen PJ, Moore RA. Clonazepam for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;(5):CD009486.

    Google Scholar 

  30. Gill D, Derry S, Wiffen PJ, Moore RA. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;(10):CD009183.

    Google Scholar 

  31. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114(7):537–45.

    Article  CAS  PubMed  Google Scholar 

  32. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52(8):2495–505.

    Article  CAS  PubMed  Google Scholar 

  33. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369(9565):946–55.

    Article  PubMed  Google Scholar 

  34. Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Effects of treatment of myofascial trigger points on the pain of fibromyalgia. Curr Pain Headache Rep. 2011;15(5):393–9.

    Article  PubMed  Google Scholar 

  35. Lewit K. The needle effect in the relief of myofascial pain. Pain. 1979;6(1):83–90.

    Article  CAS  PubMed  Google Scholar 

  36. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82(7):986–92.

    Article  CAS  PubMed  Google Scholar 

  37. Esenyel M, Caglar N, Aldemir T. Treatment of myofascial pain. Am J Phys Med Rehabil. 2000;79(1):48–52.

    Article  CAS  PubMed  Google Scholar 

  38. Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain. 2002;18(6):S147–54.

    Article  PubMed  Google Scholar 

  39. Wheeler AH, Goolkasian P, Gretz SS. A randomized, doubleblind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine. 1998;23:1662–6.

    Article  CAS  PubMed  Google Scholar 

  40. Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for lowback pain. Spine. 1989;14:962–4.

    Article  CAS  PubMed  Google Scholar 

  41. Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994;73:256–63.

    Article  CAS  PubMed  Google Scholar 

  42. Panton L, Simonavice E, Williams K, Mojock C, Kim JS, Kingsley JD, McMillan V, Mathis R. Effects of class IV laser therapy on fibromyalgia impact and function in women with fibromyalgia. J Altern Complement Med. 2012;18:1–8.

    Article  Google Scholar 

  43. Johnson JL, Collo MB, Finch WR, Felicetta JV. Fibromyalgia syndrome. J Am Acad Nurse Pract. 1990;2(2):47–53.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Johns Hopkins Hospital, Baltimore, MD, USA

    Levan Atanelov M.D., M.S., B.S.

Authors
  1. Levan Atanelov M.D., M.S., B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Levan Atanelov M.D., M.S., B.S. .

Editor information

Editors and Affiliations

  1. Department of Rehabilitation Medicine, Interventional Pain Management, New York University , Langone Medical Center, New York, New York, USA

    Kimberly A. Sackheim

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Atanelov, L. (2015). Fibromyalgia. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2462-2_25

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2461-5

  • Online ISBN: 978-1-4939-2462-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation